Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status. 2026 | PubMed
Impact of concurrent lobular carcinoma in situ on recurrence outcomes in patients with classic and pleomorphic invasive lobular carcinoma of the breast. 2025 | PubMed
A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy. 2026 | PubMed
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial. 2025 | UCSF Research Profile
Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue. 2026 | PubMed
Cryoablation Versus Breast-Conserving Surgery for Early-Stage, Low-Risk Breast Cancer ≤ 1.5 cm: A Cost-Effectiveness Analysis. 2025 | PubMed
Tailoring Management for Invasive Lobular Carcinoma: Imaging, Surgical Treatment, and Systemic Therapy Considerations. 2026 | PubMed
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial. 2025 | PubMed
Locoregional Considerations for Invasive Lobular Carcinoma. 2025 | PubMed
FNA biopsy of breast specimens effectively harvests cells for patient-derived organoids modeling ductal carcinoma in situ. 2025 | PubMed